GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists These agents are commonly used therapies for managing diabetes and obesity, but gastrointestinal adverse effects such as nausea, vomiting, diarrhea, and constipation frequently limit therapy
Zhenqi Liu and former UVA graduate student Nathan Weeldreyer, found about 40% of the weight people lose using brand-name drugs like Wegovy or Zepbound comes from something called fat-free mass, which is everything in your body that is not fat
Their single-molecule design optimally integrated the incretin effects of both hormones, demonstrating superior efficacy compared to traditional GLP-1RAs
GLP1s delay gastric emptying which causes food to sit in the stomach for longer periods of time, which triggers nausea, says Micheal Currier, PA-C, The other mechanism resides in the central nervous system and is due to how the medication activates GLP-1 receptors in the area of the brain that controls nausea and vomiting, which then leads to an increase in nausea. How common is nausea on GLP-1 drugs